alexa Mohammad Hojat Farsangi | Karolinska University
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mohammad Hojat Farsangi

Mohammad Hojat Farsangi Mohammad Hojat Farsangi
Assistant Professor
Karolinska University

Dr Mohammad Hojjat-Farsangi has received his PhD in Medical Immunology and targeted Cancer Therapy from Tehran university of Medical Sciences, Tehran, Iran during the period of 2004-2009. Currently, he is working as assistant professor in Karolinska University, Stockholm, Sweden. He has successfully completed two Post-Doctoral periods on Targeted Based cancer Therapy with focus or ROR1 receptor tyrosine kinase. He is serving as an expert Reviewers for journals like Tumor Biology, Leukemia, Hepatitis Monthly, Human Vaccines & Immunotherapeutics and Medical Oncology. He authored more than 30 research and articles.

Research Interest

Tumor Biology, Leukemia, Hepatitis, Human Vaccines

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version